Why the study?
Cardiac autonomic neuropathy has been suggested to be associated with hypoglycemia and impaired hypoglycemia unawareness, prompting assessment of its relationship with extensive glucose variability measures in diabetes.
Is cardiovascular autonomic neuropathy associated with increased glycemic variability in patients with diabetes?
Population
40 participants with type 1 and type 2 diabetes
Comparison
Participants with CAN vs without CAN
Key result
Cardiac autonomic neuropathy in patients with diabetes was associated with increased glycemic variability, including higher CONGA (8.42 vs 6.68; P=0.024) and greater time in hyperglycemia.
Authors
Loading...
Hypothesis-generating for CAN-glycemic variability links in diabetes; prospective studies needed before clinical adoption.
Cross-Sectional (n=40)
Is cardiovascular autonomic neuropathy associated with increased glycemic variability in patients with diabetes?
Absolute Event Rate: 8.42% vs 6.68%
p-value: p=0.024
Cardiovascular autonomic neuropathy in patients with diabetes is associated with increased glycemic variability driven primarily by greater time spent in hyperglycemia rather than hypoglycemia.
Gad et al. (2023) conducted a cross-sectional in Type 1 and Type 2 diabetes (n=40). Cardiac autonomic neuropathy vs. No cardiac autonomic neuropathy was evaluated on Continuous overall net glycemic action (CONGA) (p=0.024). Cardiac autonomic neuropathy in patients with diabetes was associated with increased glycemic variability, including higher CONGA (8.42 vs 6.68; P=0.024) and greater time in hyperglycemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: